Knowledge Center

Article / Jan 01, 2011

What is Special About Inhalation APIs?

Authors:
  • Carla Vozone
Source:
Drug Development and Delivery, January 2011

What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.

Related links

Read article here

Also in the Knowledge Center

Related Content

Covid-19 / Coronavirus

Stay updated with the latest information on Covid-19

Page
Read more

High value applications

Hovione provides off-patent APIs that can be used with confidence where the choice of active ingredient is critical.

Page
Read more

Technologies

We offer a number of innovative particle engineering technologies, at all scales, to address recent challenges in drug delivery.

Page
Read more